BCL2 and Friedreich ataxia: Obviously, with the treatment of FA, the key pathways of apoptosis BAX and BCL-2 are significantly changed, the tumor suppressor-related gene BCL-2 is inhibited, and the apoptosis-promoting gene BAX is enhanced.